News
Hyrodsense PRO proven to deliver 100% accurate on-site Legionella detection
Leading industry publications have recently highlighted that Hydrosense PRO has been proven to deliver 100% accurate, on-site Legionella detection. With Legionnaires’ disease cases on the rise, rapid and reliable testing is more critical than ever, helping
GlobalPets (& PETS International Magazine) feature MiAlgae
MiAlgae, an Equity Gap Portfolio, is positioned to “transform” the pet industry with its omega-3 producing technology. The Edinburgh-based company is set to open a new plant in Scotland’s central belt, quadrupling production capacity and driving
Brewgooder launch Dripp Passion Fruit and Guava in major supermarket chains
Equity Gap portfolio company, Brewgooder, recently launched, on a nationwide basis, their Dripp Passion Fruit and Guava craft beer offerings in Sainsbury’s and Tesco stores.
Congratulations to EnteroBiotix
Equity Gap were delighted to congratulate their portfolio company, EnteroBiotix, on two counts. Winning the ‘Innovation – Pharma Services & Drug Discovery Award’ at the Scottish Life Science Event in Glasgow and they announced the positive
Trojan to supply Camden Council with an additional 570 EV charge points
Camden Council has awarded a major contract to Trojan Energy to install an additional 570 flat & flush points in their borough, once suitable locations are identified, enabling residents without driveways to easily charge their EVs.
Shot Scope CEO, David Hunter, shares his incredible journey with Edinburgh Business Stories
Equity Gap’s portfolio company CEO, David Hunter of Shot Scope, shares his incredible journey with Edinburgh Business Stories from engineer to school teacher to entrepreneur and CEO. Equity Gap thanks Edinburgh Business Stories for featuring Shot Scope, and
Eve Hanks, CEO of MI:RNA, named in TechRound’s Top 50 Women in Tech 2025
Every year TechRound highlights female business owners who are innovative and creating the future of tech in the UK and Europe. In 2025 Eve has been recognised for her ground breaking work in diagnostics for animals
Lentitek secures £700k investment from Equity Gap and existing investors
Lentitek, the Edinburgh-based biotech company who are revolutionising viral vector technology for next generation CAR-T cell and gene therapies, recently secured a further investment of £700k from Equity Gap and other existing investors including Gabriel Investment